−14.2797USD
−25.97 MUSD
2.27 M
About GeoVax Labs, Inc.
Sector
Industry
CEO
David A. Dodd
Website
Headquarters
Smyrna
Employees (FY)
17
Founded
1988
FIGI
BBG00XLXN1L0
GeoVax Labs, Inc. is a clinical-stage biotechnology company, which engages in the development of human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms. It focuses on preventive vaccines against hemorrhagic fever viruses such as Ebola, Sudan, Marburg, and Lassa fever, the Zika virus and malaria, and human immunodeficiency virus, as well as immunotherapies for solid tumor cancers. The company was founded in June 1988 and is headquartered in Smyrna, GA.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
